NOT KNOWN DETAILS ABOUT FENTANYL TOXICITY SIGNS AND SYMPTOMS

Coadministration of pexidartinib (a CYP3A4 inducer) with delicate CYP3A substrates could bring about significant therapeutic failures. If concomitant use is unavoidable, raise the CYP3A substrate dosage in accordance with authorized product labeling.If coadministration of CYP3A4 inhibitors with fentanyl is important, watch patients for respiratory